Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of Tumor-informed Circulating Tumor DNA Detectability Before and After Radical Cystectomy with Disease-free Survival in Patients with Bladder Cancer.
Sfakianos JP, Basu A, Laliotis G, Cumarasamy S, Rich JM, Kommalapati A, Glover M, Mahmood T, Tillu N, Hoimes CJ, Selig G, Kollipara R, Stewart TF, Rivero-Hinojosa S, Dutta P, Calhoun M, Sharma S, Malhotra M, ElNaggar AC, Liu MC, Ferguson JE 3rd, Diniz M, Mehrazin R, Wiklund P, Tan A, Shah S, Galsky MD. Sfakianos JP, et al. Among authors: laliotis g. Eur Urol Oncol. 2024 Jul 15:S2588-9311(24)00174-3. doi: 10.1016/j.euo.2024.07.001. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39013741 Free article.
Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up.
Lindskrog SV, Birkenkamp-Demtröder K, Nordentoft I, Laliotis G, Lamy P, Christensen E, Renner D, Andreasen TG, Lange N, Sharma S, ElNaggar AC, Liu MC, Sethi H, Aleshin A, Agerbæk M, Jensen JB, Dyrskjøt L. Lindskrog SV, et al. Among authors: laliotis g. Clin Cancer Res. 2023 Dec 1;29(23):4797-4807. doi: 10.1158/1078-0432.CCR-23-1860. Clin Cancer Res. 2023. PMID: 37782315 Free PMC article.
Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.
Cecchini M, Salem RR, Robert M, Czerniak S, Blaha O, Zelterman D, Rajaei M, Townsend JP, Cai G, Chowdhury S, Yugawa D, Tseng R, Mejia Arbelaez C, Jiao J, Shroyer K, Thumar J, Kortmansky J, Zaheer W, Fischbach N, Persico J, Stein S, Khan SA, Cha C, Billingsley KG, Kunstman JW, Johung KL, Wiess C, Muzumdar MD, Spickard E, Aushev VN, Laliotis G, Jurdi A, Liu MC, Escobar-Hoyos L, Lacy J. Cecchini M, et al. Among authors: laliotis g. JAMA Oncol. 2024 Aug 1;10(8):1027-1035. doi: 10.1001/jamaoncol.2024.1575. JAMA Oncol. 2024. PMID: 38900452 Free PMC article. Clinical Trial.
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma.
Botta GP, Abdelrahim M, Drengler RL, Aushev VN, Esmail A, Laliotis G, Brewer CM, George GV, Abbate SM, Chandana SR, Tejani MA, Malla M, Bansal D, Rivero-Hinojosa S, Spickard E, McCormick N, Cecchini M, Lacy J, Fei N, Kasi PM, Kasi A, Dayyani F, Hanna DL, Sharma S, Malhotra M, Aleshin A, Liu MC, Jurdi A. Botta GP, et al. Among authors: laliotis g. Oncologist. 2024 Oct 3;29(10):859-869. doi: 10.1093/oncolo/oyae155. Oncologist. 2024. PMID: 39022993 Free PMC article.
ctDNA-based molecular residual disease and survival in resectable colorectal cancer.
Nakamura Y, Watanabe J, Akazawa N, Hirata K, Kataoka K, Yokota M, Kato K, Kotaka M, Kagawa Y, Yeh KH, Mishima S, Yukami H, Ando K, Miyo M, Misumi T, Yamazaki K, Ebi H, Okita K, Hamabe A, Sokuoka H, Kobayashi S, Laliotis G, Aushev VN, Sharma S, Jurdi A, Liu MC, Aleshin A, Rabinowitz M, Bando H, Taniguchi H, Takemasa I, Kato T, Kotani D, Mori M, Yoshino T, Oki E. Nakamura Y, et al. Among authors: laliotis g. Nat Med. 2024 Nov;30(11):3272-3283. doi: 10.1038/s41591-024-03254-6. Epub 2024 Sep 16. Nat Med. 2024. PMID: 39284954 Free PMC article.
Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY.
Kataoka K, Mori K, Nakamura Y, Watanabe J, Akazawa N, Hirata K, Yokota M, Kato K, Kotaka M, Yamazaki K, Kagawa Y, Mishima S, Ando K, Miyo M, Yukami H, Laliotis G, Sharma S, Palsuledesai CC, Rabinowitz M, Jurdi A, Liu MC, Aleshin A, Kotani D, Bando H, Taniguchi H, Takemasa I, Kato T, Yoshino T, Oki E. Kataoka K, et al. Among authors: laliotis g. Ann Oncol. 2024 Nov;35(11):1015-1025. doi: 10.1016/j.annonc.2024.08.2240. Epub 2024 Sep 16. Ann Oncol. 2024. PMID: 39293512 Free article.
Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinoma.
Yoo C, Jeong H, Jeong JH, Kim KP, Lee S, Ryoo BY, Hwang DW, Lee JH, Moon DB, Kim KH, Lee SS, Song TJ, Oh D, Lee MA, Chon HJ, Lee JS, Laliotis G, Rivero-Hinojosa S, Spickard E, Renner D, Dutta P, Palsuledesai CC, Sharma S, Malhotra M, Jurdi A, Liu MC. Yoo C, et al. Among authors: laliotis g. J Hepatol. 2024 Nov 10:S0168-8278(24)02666-7. doi: 10.1016/j.jhep.2024.10.043. Online ahead of print. J Hepatol. 2024. PMID: 39532185 Free article.
Assessment of circulating tumor DNA in patients with locally advanced rectal cancer treated with neoadjuvant therapy.
Molinari C, Marisi G, Laliotis G, Spickard E, Rapposelli IG, Petracci E, George GV, Dutta P, Sharma S, Malhotra M, Prochowski Iamurri A, Feliciani G, Liu MC, Ulivi P, Canale M, Saragoni L, Gallo G, Frassineti GL, Muratore M, Romeo A, Jurdi A, Martinelli G, Passardi A. Molinari C, et al. Among authors: laliotis g. Sci Rep. 2024 Nov 28;14(1):29536. doi: 10.1038/s41598-024-80855-8. Sci Rep. 2024. PMID: 39604448 Free PMC article.
41 results